Since anti-VEGFA, bevacizumab, was widely used for the prevention of various cancers [30], silence of ZFAS1 might be a promising therapeutic strategy for the prevention of endometrial carcinoma through inhibition of VEGFA. This evidence concerns the gene VEGFA and endometrial carcinoma.